Suppr超能文献

190例前庭神经鞘瘤患者接受直线加速器引导的立体定向放射外科治疗后的局部控制和功能结果。

Results for local control and functional outcome after linac-based image-guided stereotactic radiosurgery in 190 patients with vestibular schwannoma.

作者信息

Badakhshi Harun, Graf Reinhold, Böhmer Dirk, Synowitz Michael, Wiener Edzard, Budach Volker

机构信息

Departments for Radiation Oncology, Charité University Medicine Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.

出版信息

J Radiat Res. 2014 Mar 1;55(2):288-92. doi: 10.1093/jrr/rrt101. Epub 2013 Aug 26.

Abstract

BACKGROUND

We assessed local control (LC) and functional outcome after linac-based stereotactic radiosurgery (SRS) for vestibular schwannoma (VS).

METHODS

Between 1998 and 2008, 190 patients with VS were treated with SRS. All patients had tumors <2 cm diameter. Patients received 13.5 Gy prescribed to the 80th isodose at the tumor margin. The primary endpoint was LC. Secondary endpoints were symptomatic control and morbidity.

RESULTS

Median follow-up was 40 months. LC was achieved in 88% of patients. There were no acute reactions exceeding Grade I. Trigeminal nerve dysfunction was present in 21.6% (n = 41) prior to SRS. After treatment, 85% (n = 155) had no change, 4.4,% (n = 8) had a relief of symptoms, 10.4% (n = 19) had new symptoms. Facial nerve dysfunction was present in some patients prior to treatment, e.g. paresis (12.6%; n = 24) and dysgeusia (0.5%; n = 1). After treatment 1.1% (n = 2) reported improvement and 6.1% (n = 11) experienced new symptoms. Hearing problems before SRS were present in 69.5% of patients (n = 132). After treatment, 62.6% (n = 144) had no change, 10.4% (n = 19) experienced improvement and 26.9% (n = 49) became hearing impaired.

CONCLUSION

This series of SRS for small VS provided similar LC rates to microsurgery; thus, it is effective as a non-invasive, image-guided procedure. The functional outcomes observed indicate the safety and effectiveness of linac-based SRS. Patients may now be informed of the clinical equivalence of SRS to microsurgery.

摘要

背景

我们评估了基于直线加速器的立体定向放射外科治疗(SRS)前庭神经鞘瘤(VS)后的局部控制(LC)和功能结果。

方法

1998年至2008年间,190例VS患者接受了SRS治疗。所有患者的肿瘤直径均<2 cm。患者在肿瘤边缘接受13.5 Gy的剂量,该剂量规定在第80等剂量线上。主要终点是LC。次要终点是症状控制和发病率。

结果

中位随访时间为40个月。88%的患者实现了LC。没有超过I级的急性反应。SRS治疗前,21.6%(n = 41)的患者存在三叉神经功能障碍。治疗后,85%(n = 155)的患者症状无变化,4.4%(n = 8)的患者症状缓解,10.4%(n = 19)的患者出现新症状。一些患者在治疗前存在面神经功能障碍,例如轻瘫(12.6%;n = 24)和味觉障碍(0.5%;n = 1)。治疗后,1.1%(n = 2)的患者报告症状改善,6.1%(n = 11)的患者出现新症状。SRS治疗前,69.5%(n = 132)的患者存在听力问题。治疗后,62.6%(n = 144)的患者听力无变化,10.4%(n = 19)的患者听力改善,26.9%(n = 49)的患者听力受损。

结论

这一系列针对小型VS的SRS治疗提供了与显微手术相似的LC率;因此,它作为一种非侵入性的、图像引导的手术是有效的。观察到的功能结果表明基于直线加速器的SRS的安全性和有效性。现在可以告知患者SRS与显微手术在临床上的等效性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7aa3/3951065/bfc73ce8f5a2/rrt10101.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验